PTC Therapeutics terminates $302.1M credit agreement, pays $82.1M in prepayment premiums

PTC THERAPEUTICS, INC.

Terminated Credit Agreement dated Oct 27, 2022; repaid $302.1M principal plus accrued interest.
Paid additional $82.1M in prepayment premiums, expenses, and other exit fees.
All liens and security interests securing loans under the Credit Agreement were released.

item 1.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

PTC THERAPEUTICS, INC. terminated Credit Agreement valued at $302.1 million (effective 2023-10-19).

Action: termination
Agreement: credit facility
Value: $302.1 million
Effective: 2023-10-19

Exact text from the filing

On October 19, 2023, the Company terminated the Credit Agreement, dated October 27, 2022, by and among the Company, as the borrower, each subsidiary of the Company from time to time party thereto, as guarantors, the lenders from time to time party thereto and Wilmington Trust National Association, as administrative agent (the "Credit Agreement").

View on SEC.gov

Browse all material agreements →

PTC THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001070081-23-000059

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.